• About us
• Contact

Advertisement

Product › Details

CNS drug_o

	Next higher product group	CNS drug (neurological drug)

Record changed: 2023-07-10

Advertisement

More documents for CNS drug_o

• [1] VectorY Therapeutics B.V.. (12/16/24). "Press Release: VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO". Amsterdam & Boston, MA....
• [2] PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ....
• [3] Engrail Therapeutics, Inc.. (3/19/24). "Press Release: Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies". San Diego, CA....
• [4] Vico Therapeutics B.V.. (1/5/24). "Press Release: Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline". Leiden....
• [5] VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam....
• [6] Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus....
• [7] Evotec SE. (9/2/21). "Press Release: Evotec Announces Bristol Myers Squibb Opt-in of EVT8683 as the First Programme from iPSC-based Neurodegeneration Collaboration". Hamburg....
• [8] Vico Therapeutics B.V.. (6/29/21). "Press Release: US FDA Grants Vico Therapeutics Orphan-Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia". Leiden....
• [9] Vico Therapeutics B.V.. (2/10/21). "Press Release: European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia". Leiden....
• [10] Vico Therapeutics B.V.. (10/1/20). "Press Release: Dutch Vico Therapeutics Strengthens Leadership Team with the Appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director". Leiden....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.